Multiple clinicopathologic factors affect prognosis and therefore the outcome of management in patients with BC, including histological type, grade, stage, status of ER, PR and Her2/neu, BRCA 1 status [33, 34]. This evidence concerns the gene ESR1 and breast cancer.